Open AccessOsimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario
Author(s) -
Sayanta Thakur,
Debasis Chakraborty,
Sandeep Lahiry,
Shouvik Choudhury
Publication year - 2020
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_291_19
Subject(s) - afatinib , osimertinib , t790m , gefitinib , epidermal growth factor receptor , medicine , cancer research , erlotinib , lung cancer , tyrosine kinase , pharmacology , cancer , oncology , receptor